Grifols, S.A. logo

Grifols, S.A.

MSE:GRF.MC

Overview | Financials
Company Name Grifols, S.A.
Symbol GRF.MC
Currency EUR
Price 9.846
Market Cap 6,148,458,189
Dividend Yield 0%
52-week-range 6.362 - 15.92
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Thomas H. Glanzmann
Website https://www.grifols.com

An error occurred while fetching data.

About Grifols, S.A.

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening

Related Stocks

Fisher & Paykel Healthcare Corporation Limited logo

Fisher & Paykel Healthcare Corporation Limited

FPH.NZ

20.7 NZD

bioMérieux S.A. logo

bioMérieux S.A.

BIM.PA

106.6 EUR

Ipsen S.A. logo

Ipsen S.A.

IPN.PA

116.8 EUR

UCB SA logo

UCB SA

UCB.BR

176.7 EUR

argenx SE logo

argenx SE

ARGX.BR

441.9 EUR

Eurofins Scientific SE logo

Eurofins Scientific SE

ERF.PA

56.22 EUR

Odontoprev S.A. logo

Odontoprev S.A.

ODPV3.SA

10.55 BRL

Ryman Healthcare Limited logo

Ryman Healthcare Limited

RYM.NZ

5.43 NZD

Fleury S.A. logo

Fleury S.A.

FLRY3.SA

14.91 BRL

Financière de Tubize SA logo

Financière de Tubize SA

TUB.BR

141 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD